Discovery of key biomarkers in tourette syndrome by network pharmacology

<i>OPRM1</i> and <i>MAPT,</i> and the signaling pathways are associated with TS. YXD exerts its therapeutic TS through multi-component and multi-targets including immune infiltration.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2024-09-10
DOI
https://doi.org/10.3389/fphar.2024.1397203
Primary Topic
Obsessive-Compulsive Spectrum Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Discovery of key biomarkers in tourette syndrome by network pharmacology

Jiali Zhao, Xiaohong Bai
Frontiers in Pharmacology
Obsessive-Compulsive Spectrum Disorders
article

Discovery of key biomarkers in tourette syndrome by network pharmacology

Jiali Zhao, Xiaohong Bai
article en

Abstract

<i>OPRM1</i> and <i>MAPT,</i> and the signaling pathways are associated with TS. YXD exerts its therapeutic TS through multi-component and multi-targets including immune infiltration.

Frontiers in PharmacologyVol. 15
Liaoning University of Traditional Chinese Medicine (CN), First Affiliated Hospital of Heilongjiang University of Chinese Medicine (CN), Affiliated Hospital of Liaoning University of Traditional Chinese Medicine (CN)
Openalex Percentile: Top 79%
Obsessive-Compulsive Spectrum Disorders
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.